EW Financial Facts

Basic (in shares): 213.2M
Interest (income) expense, net: 2.1M
See Full Income Statement

Other current assets: 66.1M
Total liabilities and stockholders' equity: 4.34B
See Full Balance Sheet

Edwards Lifesciences Corp. (EW) Earnings

  |   Expand Research on EW
Next EPS Date 7/28/22 EPS Growth Rate 0.0%
Average EPS % Beat Rate +3.6% Revenue Growth Rate +0.7%
Average % Move 1-Wk after EPS -0.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/28/22 Q222 N/A$0.64 N/A N/A$1.41B = N/A N/A
4/26/22 Q122 $0.60$0.57 +$0.03$1.34B$1.31B = Details
1/26/22 Q421 $0.51$0.55 -$0.04$1.33B$1.36B = Details
10/27/21 Q321 $0.54$0.54 $0.00$1.3B$1.33B = Details
7/29/21 Q221 $0.64$0.55 +$0.09$1.4B$1.28B Details
4/20/21 Q121 $0.54$0.48 +$0.06$1.2B$1.16B Details
1/27/21 Q420 $0.50$0.53 -$0.03$1.2B$1.19B Details
10/21/20 Q320 $0.51$0.44 +$0.07$1.1B$1.08B Details